Www.iarx.org



Influenza Vaccine Information*ManufacturerTrade Name How SuppliedAge GroupRouteVaccineCSL LimitedAfluria 0.5 mL (single-dose syringe)9 years & older**IMIIV35.0 mL (multi-dose vial)GlaxoSmithKlineFluarix0.5 mL (single-dose syringe)≥ 36 mosIMIIV3Fluarix Quadrivalent0.5 mL (single-dose syringe)IMIIV4ID Biomedical Corp of Quebec, a subsidiary of GlaxoSmithKlineFluLaval5.0 mL (multi-dose vial)≥36 mosIMIIV3FluLaval Quadrivalent5.0 mL (multi-dose vial)IMIIV4Protein Sciences CorporationFlublok (no egg?proteins, antibiotics, or preservatives)0.5 mL (single-dose vial)18 - 49 yearsIMRecombinantMedimmuneFluMist Quadrivalent0.2 mL (single-use nasal spray)2 - 49 yearsINLAIV, QuadrivalentNovartis VaccinesFluvirin0.5 mL (single-dose syringe)≥4 yearsIMIIV35.0 mL (multi-dose vial)Flucelvax0.5 mL (single-dose syringe)≥18IMIIV3Sanofi PasteurFluzone 0.25 mL (single-dose syringe)6 - 35 mosIMIIV30.5 mL (single-dose syringe)≥ 36 mos0.5 mL (single-dose vial)≥ 36 mos5.0 mL (multi-dose vial)6 – 35 mosFluzone High-Dose 0.5 mL (single-dose syringe)≥ 65 years IMIIV3 High DoseFluzone Intradermal0.1 mL (single-dose microinjection system)18 - 64 yearsIDIIV3Fluzone Quadrivalent0.25 mL (single-dose syringe); 6 - 35 monthsIIV40.5 mL(single-dose syringe)≥ 36 months0.5 mg (single-dose vial)≥ 36 months5.0 mL (multi-dose vial)≥ 6 monthsAbbreviations: ID = intradermal; IM = intramuscular; IN = intranasal; LAIV = live-attenuated influenza vaccine; IIV4 = quadrivalent inactivated vaccine; IIV3 = trivalent inactivated vaccine * Vaccination providers should consult Food and Drug Administration–approved prescribing information for influenza vaccines for the most updated information, including indications, contraindications, and precautions**Age indication per package insert is ≥5 years; however, the Advisory Committee on Immunization Practices recommends that Afluria not be used in children aged 6 months through 8 years because of increased risk for febrile reactions noted in this age group with CSL's 2010 Southern Hemisphere TIV. If no other age-appropriate, licensed inactivated seasonal influenza vaccine is available for a child aged 5 through 8 years who has a medical condition that increases the child's risk for influenza complications, Afluria can be used; however, vaccination providers should discuss with the parents or caregivers the benefits and risks of influenza vaccination with Afluria before administering this vaccine. Afluria may be used in persons aged ≥9 years.Resources:Influenza Vaccine Products for the 2013-2014 Influenza Season. Immunization Action Coalition. Sep 2013. . Influenza Vaccine Information, by age group --- United States, 2014—15 influenza season. Center for Disease Control and Prevention. Page last updated October 29, 2012. . Consulted manufacturer package inserts for each vaccine product. updated August 18, 2014 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download